Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.5.4, replacing v3.5.3. This indicates a minor version update to the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:58:04.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page’s embedded revision/version label was updated from `v3.5.2` to `v3.5.3`, indicating a content-management or site release rather than an update to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-26T08:07:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.5.2 released. Previous version: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T01:19:47.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be a backend version update with no visible changes to study details.
    Difference
    0.1%
    Check dated 2026-03-21T08:00:48.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T18:25:36.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1. No user-facing content or functional changes are evident from the available context.
    Difference
    0.1%
    Check dated 2026-02-13T12:48:51.000Z thumbnail image

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.